AR107829A1 - Monotartrato de vinorelbina y su uso farmacéutico - Google Patents

Monotartrato de vinorelbina y su uso farmacéutico

Info

Publication number
AR107829A1
AR107829A1 ARP170100572A ARP170100572A AR107829A1 AR 107829 A1 AR107829 A1 AR 107829A1 AR P170100572 A ARP170100572 A AR P170100572A AR P170100572 A ARP170100572 A AR P170100572A AR 107829 A1 AR107829 A1 AR 107829A1
Authority
AR
Argentina
Prior art keywords
monotartrate
crystalline
vinorelbin
vinorelbine monotartrate
pharmaceutical use
Prior art date
Application number
ARP170100572A
Other languages
English (en)
Inventor
Volodymyr Sypchenko
Iaroslav Matviienko
Christian Schickaneder
Vladimir Matha
Viktor Matviyenko
Oleksandr Zabudkin
Original Assignee
Synbias Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synbias Pharma Ag filed Critical Synbias Pharma Ag
Publication of AR107829A1 publication Critical patent/AR107829A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Monotartrato de vinorelbina cristalino y su uso para la prevención y el tratamiento del cáncer, particularmente el cáncer de pulmón no microcítico o el cáncer de mama. También se refiere a un método correspondiente para la fabricación de monotartrato de vinorelbina cristalino. Reivindicación 10: El monotartrato de vinorelbina cristalino de acuerdo con la reivindicación 8 ó 9, caracterizado porque el monotartrato de vinorelbina hidrato cristalino se caracteriza por un patrón de difracción de polvo de rayos X que comprende picos a ángulos de difracción promedio (2q) de 7,9º, 9,5º, 10,3º, 10,8º, y 13,4º, 13,6º y 14,5º (cada ± 0,2º).
ARP170100572A 2016-03-09 2017-03-08 Monotartrato de vinorelbina y su uso farmacéutico AR107829A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2016/055040 WO2017152972A1 (en) 2016-03-09 2016-03-09 Vinorelbine monotartrate and its pharmaceutical use

Publications (1)

Publication Number Publication Date
AR107829A1 true AR107829A1 (es) 2018-06-13

Family

ID=55521706

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100572A AR107829A1 (es) 2016-03-09 2017-03-08 Monotartrato de vinorelbina y su uso farmacéutico

Country Status (11)

Country Link
US (1) US20190092792A1 (es)
EP (1) EP3426665A1 (es)
JP (1) JP2019508436A (es)
CN (1) CN108779129A (es)
AR (1) AR107829A1 (es)
BR (1) BR112018067637A2 (es)
CA (1) CA3014473A1 (es)
RU (1) RU2730521C2 (es)
TW (1) TW201734023A (es)
UY (1) UY37139A (es)
WO (1) WO2017152972A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115611927A (zh) * 2020-01-06 2023-01-17 刘力 长春抗肿瘤药物的新化合物
CN114621258B (zh) * 2022-04-08 2024-06-25 海南长春花药业有限公司 一种酒石酸长春瑞滨的纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
DK1530459T3 (da) 2002-05-31 2010-07-19 Rp Scherer Technologies Llc Oral farmaceutisk sammensætning til bløde kapsler indeholdende vinorelbin samt fremgangsmåde til behandling
CN1437942A (zh) * 2003-02-08 2003-08-27 杭州华卫制药技术开发有限公司 注射用长春瑞滨粉针剂及制备方法
CN1245409C (zh) * 2003-06-03 2006-03-15 浙江海正药业股份有限公司 长春瑞滨合成中间体脱水长春碱的制备方法
CN1552716A (zh) * 2003-06-03 2004-12-08 浙江海正药业股份有限公司 合成长春瑞滨的方法
PL1830817T3 (pl) 2004-12-30 2013-06-28 Pf Medicament Stała trwała dyspersja pochodnej alkaloidu Vinca i sposób jej wytwarzania
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
CN101284842B (zh) * 2008-05-19 2010-06-09 华中科技大学 用硫酸长春碱合成长春瑞滨酒石酸盐的方法
CN102766149B (zh) * 2012-07-05 2014-09-24 深圳万乐药业有限公司 一种酒石酸长春瑞滨的制备方法
CN104725405A (zh) * 2013-12-20 2015-06-24 中国医药研究开发中心有限公司 长春瑞滨的制备方法

Also Published As

Publication number Publication date
CA3014473A1 (en) 2017-09-14
RU2018129465A (ru) 2020-04-09
RU2018129465A3 (es) 2020-04-09
JP2019508436A (ja) 2019-03-28
BR112018067637A2 (pt) 2019-01-02
UY37139A (es) 2017-10-31
TW201734023A (zh) 2017-10-01
WO2017152972A1 (en) 2017-09-14
EP3426665A1 (en) 2019-01-16
US20190092792A1 (en) 2019-03-28
RU2730521C2 (ru) 2020-08-24
CN108779129A (zh) 2018-11-09

Similar Documents

Publication Publication Date Title
CL2019003636A1 (es) Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson.
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
MX2018005019A (es) Derivado benzofurano, su metodo de preparacion, y sus usos en medicinas.
MX2017013801A (es) Métodos para tratar el cáncer.
CL2016001895A1 (es) Compuestos
TW201613901A (en) New compounds
MY186977A (en) Tetrasubstituted alkene compounds and their use
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
MX2018003893A (es) Moduladores del receptor p2x3 y p2x2/3 de diaminopirimidina para usarse en el tratamiento de la tos.
PH12019501690A1 (en) Pyrimidine compound and pharmaceutical use thereof
MX2015010829A (es) Compuestos terapeuticos y sus usos.
MX2016009332A (es) Conjugado de farmaco citotoxico-ligando, metodo de preparacion del mismo y uso del mismo.
TW201711997A (en) 2-arylamino pyridine, pyridine or triazine derivative, preparation method and use thereof
MX2017015936A (es) Nueva composicion farmaceutica que comprende agentes tensioactivos no ionicos.
MX2017006437A (es) Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor.
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
IN2014MU00303A (es)
CL2018003431A1 (es) Tratamiento de la enfermedad de parkinson.
MX2016016388A (es) Uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de pulmon de celula no pequeña y/o cancer de pulmon de celula pequeña.
CO2019002361A2 (es) 1–arilnaftiridin–3–carboxamidas 7–sustituidas y su uso
PH12016501039A1 (en) Pharmaceutical dosage forms
CO2020004984A2 (es) Proceso para preparar el benzotiofen-2-il boronato
MX2017006513A (es) Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor.
AR107829A1 (es) Monotartrato de vinorelbina y su uso farmacéutico
MX2019000677A (es) Células miméticas de células b.

Legal Events

Date Code Title Description
FB Suspension of granting procedure